Daclatasvir Dihydrochloride and Incobotulinumtoxina Intramuscular
Determining the interaction of Daclatasvir Dihydrochloride and Incobotulinumtoxina Intramuscular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: incobotulinumtoxinA
Brand name: Xeomin
Synonyms: Incobotulinumtoxina (Intramuscular)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Increlex
- Daclatasvir Dihydrochloride-Incruse Ellipta
- Daclatasvir Dihydrochloride-Indacaterol
- Daclatasvir Dihydrochloride-Indacaterol and Glycopyrrolate
- Daclatasvir Dihydrochloride-Indacaterol and glycopyrrolate Inhalation
- Daclatasvir Dihydrochloride-Indacaterol inhalation
- Incobotulinumtoxina Intramuscular-Daclizumab
- Incobotulinumtoxina Intramuscular-Daclizumab Subcutaneous
- Incobotulinumtoxina Intramuscular-Dacogen
- Incobotulinumtoxina Intramuscular-Dacomitinib
- Incobotulinumtoxina Intramuscular-Dactinomycin
- Incobotulinumtoxina Intramuscular-Dactinomycin Injection